Lifecare AS

Oslo Stock Exchange LIFE.OL

Lifecare AS Price to Sales Ratio (P/S) on January 14, 2025: 16.74

Lifecare AS Price to Sales Ratio (P/S) is 16.74 on January 14, 2025, a 401.89% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Lifecare AS 52-week high Price to Sales Ratio (P/S) is 26.19 on October 02, 2024, which is 56.48% above the current Price to Sales Ratio (P/S).
Lifecare AS 52-week low Price to Sales Ratio (P/S) is 1.25 on August 06, 2024, which is -92.52% below the current Price to Sales Ratio (P/S).
Lifecare AS average Price to Sales Ratio (P/S) for the last 52 weeks is 6.74.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Oslo Stock Exchange: LIFE.OL

Lifecare AS

CEO	Mr. Joacim Holter
IPO Date	July 11, 2018
Location	Norway
Headquarters	Ytrebygdsvegen 215
Employees	32
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. It develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. The company was founded in 2006 and is headquartered in Bergen, Norway.

Key trends

Past 5 years